Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 159 Neoplasms 116 Carcinoma, Non-Small-Cell Lung 91 Colorectal Neoplasms 86 Prostatic Neoplasms 85 Lung Neoplasms 78 Leukemia, Myeloid, Acute 54 Carcinoma, Hepatocellular 52 Pancreatic Neoplasms 46 Neoplasm Metastasis 44 Multiple Myeloma 38 Recurrence 35 Triple Negative Breast Neoplasms 31 Squamous Cell Carcinoma of Head and Neck 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Ovarian Neoplasms 29 Melanoma 28 Uterine Cervical Neoplasms 27 Stomach Neoplasms 27 Glioblastoma 27 Brain Neoplasms 27 Rectal Neoplasms 25 Head and Neck Neoplasms 25 Small Cell Lung Carcinoma 23 Carcinoma, Renal Cell 23 Endometrial Neoplasms 20 Lymphoma, B-Cell 19 Glioma 19 Sarcoma 18 Lymphoma, Follicular 18

Interventions

Tacrolimus 1 Sirolimus 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Pseudomyxoma Peritonei × 90 days × Clear all

NCT06084780 2026-04-09

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡